Idexx Laboratories
(IDXX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 322,536 | 279,058 | 223,986 | 183,895 | 156,915 |
| Receivables | 152,380 | 158,038 | 138,324 | 141,275 | 120,080 |
| Inventories | 160,342 | 133,427 | 140,946 | 133,099 | 127,885 |
| Income taxes - deferred | 37,689 | 33,226 | 27,714 | 25,637 | 26,203 |
| Other current assets | 86,451 | 48,957 | 38,567 | 40,321 | 29,508 |
| TOTAL | $759,398 | $652,706 | $569,537 | $524,227 | $460,591 |
| Non-Current Assets | |||||
| PPE Net | 303,587 | 281,214 | 245,177 | 216,777 | 201,725 |
| Intangibles | 249,572 | 239,365 | 237,827 | 69,209 | 55,752 |
| Other Non-Current Assets | 71,654 | 57,231 | 51,061 | 220,601 | 179,076 |
| TOTAL | $624,813 | $577,810 | $534,065 | $506,587 | $436,553 |
| Total Assets | $1,384,211 | $1,230,516 | $1,103,602 | $1,030,814 | $897,144 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,035 | 1,107 | 917 | 863 |
| Accounts payable and accrued liabilities | 44,743 | 29,941 | 35,288 | 36,551 | 22,669 |
| Accrued Expenses | 195,351 | 148,919 | 137,746 | 141,383 | 118,598 |
| TOTAL | $820,906 | $478,353 | $406,333 | $436,879 | $285,112 |
| Non-Current Liabilities | |||||
| Long Term Debt | 350,000 | 150,359 | 1,394 | 2,501 | 3,418 |
| Deferred Revenues | 31,812 | 21,458 | 20,192 | 15,028 | 13,983 |
| Other Non-Current Liabilities | 32,318 | 31,221 | 23,878 | 17,762 | 11,009 |
| TOTAL | $445,716 | $233,949 | $61,012 | $54,342 | $37,751 |
| Total Liabilities | $1,266,622 | $712,302 | $467,345 | $491,221 | $322,863 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 94,251 | 103,200 | 109,159 | 110,108 | 114,671 |
| Common Shares | 10,195 | 10,119 | 10,016 | 9,923 | 9,797 |
| Retained earnings | 1,675,299 | 1,493,393 | 1,305,593 | 1,127,326 | 965,540 |
| Other shareholders' equity | -3,198 | 18,382 | 20,434 | 19,769 | 18,299 |
| TOTAL | $117,589 | $518,214 | $636,257 | $539,593 | $574,281 |
| Total Liabilities And Equity | $1,384,211 | $1,230,516 | $1,103,602 | $1,030,814 | $897,144 |